Xiaohong Cai Selected Research

Nocodazole

4/2007

ARC-111 inhibits hypoxia-mediated hypoxia-inducible factor-1alpha accumulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohong Cai Research Topics

Disease

7	Hypoxia (Hypoxemia) 01/2022 - 04/2007
6	Neoplasms (Cancer) 01/2019 - 03/2007
4	Obstructive Sleep Apnea 01/2022 - 03/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014 - 12/2002
2	Asthma (Bronchial Asthma) 11/2019 - 05/2013
2	Stomach Neoplasms (Stomach Cancer) 11/2017 - 07/2009
1	Apnea 01/2022
1	Cognitive Dysfunction 01/2020
1	COVID-19 01/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2019
1	Venous Thromboembolism 03/2019
1	Fibrosis (Cirrhosis) 02/2019
1	Inflammation (Inflammations) 02/2019
1	Non-alcoholic Fatty Liver Disease 02/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Blindness (Hysterical Blindness) 01/2017
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2017
1	Pathologic Neovascularization 01/2017
1	Hyperoxia 01/2017
1	Lung Neoplasms (Lung Cancer) 05/2014
1	Liver Diseases (Liver Disease) 06/2012
1	Diarrhea 06/2012
1	Hematologic Neoplasms (Hematological Malignancy) 05/2008
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2008
1	Adenocarcinoma 05/2008
1	Carcinogenesis 04/2007
1	von Willebrand Diseases (von Willebrand's Disease) 05/2006

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2022 - 04/2007
3	Messenger RNA (mRNA)IBA 02/2019 - 05/2013
2	Caffeine (No Doz)FDA LinkGeneric 01/2022 - 01/2017
2	Oxygen (Dioxygen)IBA 01/2017 - 04/2007
2	Proteins (Proteins, Gene)FDA Link 05/2013 - 04/2007
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 12/2002
2	Gemcitabine FDA Link 06/2012 - 12/2002
1	sulforaphaneIBA 01/2022
1	TESIBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Neuroprotective AgentsIBA 01/2020
1	1,3-dipropyl-8-cyclopentylxanthineIBA 01/2020
1	Adenosine A1 ReceptorIBA 01/2020
1	Protein Kinase CIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2019
1	Protein SIBA 03/2019
1	Protective AgentsIBA 02/2019
1	ResveratrolIBA 02/2019
1	LipidsIBA 02/2019
1	CurcuminIBA 02/2019
1	CytokinesIBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Circular RNAIBA 01/2019
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Retinaldehyde (Retinal)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	montelukast (Singulair)FDA Link 03/2015
1	MetallothioneinIBA 01/2014
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2013
1	Cyclin D1IBA 05/2013
1	OvalbuminIBA 05/2013
1	Cyclin AIBA 05/2013
1	EndostatinsIBA 06/2012
1	ProdrugsIBA 03/2012
1	NucleotidesIBA 03/2012
1	DNA (Deoxyribonucleic Acid)IBA 03/2012
1	TH 302IBA 03/2012
1	isophosphamide mustard (IPAM)IBA 03/2012
1	azomycinIBA 03/2012
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2009
1	Fluorouracil (Carac)FDA LinkGeneric 07/2009
1	Leucovorin (Folinic Acid)FDA Link 07/2009
1	Tubulin ModulatorsIBA 05/2008
1	stirocainideIBA 05/2008
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2008
1	multidrug resistance-associated protein 1IBA 05/2008
1	Antineoplastic Agents (Antineoplastics)IBA 05/2008
1	NocodazoleIBA 04/2007
1	Transcription Factors (Transcription Factor)IBA 04/2007
1	Topotecan (Hycamtin)FDA LinkGeneric 04/2007
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 04/2007
1	topovaleIBA 04/2007
1	Topoisomerase I InhibitorsIBA 04/2007
1	AcetyleneIBA 03/2007
1	Cytotoxins (Cytolysins)IBA 03/2007
1	IndazolesIBA 03/2007
1	von Willebrand FactorIBA 05/2006
1	Carboplatin (JM8)FDA LinkGeneric 12/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 04/2007
3	Drug Therapy (Chemotherapy) 11/2017 - 12/2002
2	Blood Transfusion (Blood Transfusions) 01/2020 - 05/2014